STOCK TITAN

Insider plans 90000-share sale in UTHR (NASDAQ: UTHR) under Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A Form 144 notice has been filed for the proposed sale of 90000 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of 42254100.00. The issuer reports 43056599 shares outstanding at the time of the notice.

The 90000 shares were acquired on 02/02/2026 via a cash exercise of stock options from the issuer. The filing also lists multiple prior Rule 10b5-1 common stock sales for Michael Benkowitz over the past three months, each with specified share amounts and gross proceeds.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for UTHR disclose about planned share sales?

The Form 144 reports a planned sale of 90000 shares of common stock on NASDAQ, routed through Morgan Stanley Smith Barney LLC. The aggregate market value for this proposed sale is listed as 42254100.00, based on the figures in the notice.

How were the 90000 UTHR shares in the Form 144 acquired?

The 90000 shares were acquired on 02/02/2026 through a cash exercise of stock options from the issuer. The acquisition date, transaction type, amount acquired, and payment method are all specified directly in the Form 144 securities acquisition table.

How many UTHR shares are reported outstanding in this Form 144 notice?

The notice states that 43056599 shares of the issuer’s common stock are outstanding. This figure provides context for the 90000-share planned sale, indicating the broader share base against which the proposed transaction is being made.

Which broker is handling the proposed Form 144 sale related to UTHR?

The proposed sale is listed under Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, 8th Floor, New York, NY 10004. This broker is named in the Form 144 section covering class, broker, share amount, and trading market.

What past 10b5-1 trading activity is disclosed in the UTHR Form 144?

The filing lists multiple 10b5-1 sales for Michael Benkowitz of common stock over the prior three months. Each entry specifies the trade date, number of shares sold, and gross proceeds, covering transactions from 11/03/2025 through 01/26/2026.

On which exchange is the stock in the UTHR Form 144 planned to be sold?

The Form 144 specifies that the common stock involved in the planned 90000-share sale is to be traded on NASDAQ. The exchange name appears alongside the approximate sale date, share count, aggregate market value, and shares outstanding.
United Therapeutics Corp.

NASDAQ:UTHR

UTHR Rankings

UTHR Latest News

UTHR Latest SEC Filings

UTHR Stock Data

20.21B
42.14M
1.77%
99.51%
5.97%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SILVER SPRING